by Scott Larrivee | Dec 12, 2023 | News
EVENT REPLAY NOW AVAILABLE Recorded December 19, 2023 Press release updated December 14, 2023 to include addition of Dr. Orozco VALENCIA, Calif. – Dec. 12, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it...
by Scott Larrivee | Aug 22, 2023 | News
With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
by Scott Larrivee | May 1, 2023 | News
Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
by Scott Larrivee | Apr 20, 2023 | News
NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...
by Scott Larrivee | Apr 17, 2023 | News, Utah
New domestic supply source to help address critical shortage of medical radioisotopes Proprietary platform will be capable of generating up to 12 different rare isotopes simultaneously WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping...
